Research Library

Curated Studies & Clinical Data

A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.

698Curated Studies
27Compounds Covered
9Clinical Trials
401Journals Referenced
STUDY

EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE “OLD” CHROMATIN

Lezhava T, Jokhadze T, Monaselidze J, et al.

Georgian medical news;(335):79-83

epitalon
STUDY

[Peptidergic regulation of expression of cellular aging marker proteins in buccal epithelium.]

Ivko OM, Trofimova SV, Trofimov AV, et al.

Advances in gerontology = Uspekhi gerontologii;37(5):516-524

P21
STUDY

[Semaglutide-induced acute-on-chronic liver failure: A case report and literature review]

Fu R, Wu H, Huang H, et al.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences;51(2):213-220

GLP-1 Semaglutide
STUDY

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study

Lee E, Burgess K

Alternative therapies in health and medicine;31(5):20-24

BPC-157
STUDY

Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like-Peptide-1 Use Following 10-Session Cognitive-Behavioural Therapy for Binge-Eating Disorder: A Single-Case Experimental Design

Dunford A, Yee S, Thomas JJ, et al.

European eating disorders review : the journal of the Eating Disorders Association, 2026

GLP-1 tirzepatide
STUDY

Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in Spain

Altés A, Moreno-Pérez Ó, Sastre-Belío M, et al.

Advances in therapy, 2026

Semaglutide
STUDY

Synergistic Intervention for Obesity: Integrating Central Appetite Regulation and Peripheral Energy Expenditure

Xie J, Yang Y, Chen W, et al.

Current obesity reports, 2026;15(1)

retatrutide
STUDY

Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial

Bajaj HS, Welch M, Shah P, et al.

Lancet (London, England), 2026

GLP-1 retatrutide
STUDY

Weight Loss Associated with Semaglutide Use is Linked to Improved Reproductive Measures in PMOS: a Proof-Of-Concept Analysis

Cree MG, Garcia-Reyes Y, Shapiro A, et al.

Fertility and sterility, 2026

Semaglutide
STUDY

Copper(II)-Tripeptide Complexes as Potential Skin Healing Agents: Synthesis, Characterization, and Wound Repair Ability

Aguilar L, Garcia Gabastú E, Schaffner M, et al.

ChemMedChem;21(8):e202501023

STUDY

Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes

Eldesouki MH, Alkasabrah O, Kloub M, et al.

United European gastroenterology journal;14(5):e70238

GLP-1 Semaglutide
STUDY

Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation

Mazza AD

Integrative medicine (Encinitas, Calif.);25(2):29-37

BPC-157 thymosin
STUDY

Biomimetic Hematoma Enables Healing in Complex Periprosthetic Fracture Nonunion with Multiple Comorbidities: A Case Report

Maestas A, Glatt V, Alderete JF

JBJS case connector, 2026;16(2)

tirzepatide
STUDY

Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety

Vinciguerra F, Di Stefano C, Guccione F, et al.

Obesity surgery, 2026

GLP-1 tirzepatide
PRECLINICAL / IN VIVO

Dual GIP/GLP-1 receptor agonist tirzepatide ameliorates hepatic steatosis and inflammatory responses in a MASLD mouse model associated with the CCL2/CCR2 axis

Pan Y, Song F, Liu X, et al.

BMC gastroenterology, 2026

GLP-1 Semaglutide tirzepatide
STUDY

Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes

Piraccini BM, Vañó-Galván S, Blume-Peytavi U, et al.

Dermatology and therapy, 2026

Semaglutide tirzepatide
STUDY

Rates of, Reasons for, and Reactions to Discontinuation of GLP-1 Receptor Agonists: A Narrative Review

Heisey HD, Gregg LP, Verrico CD, et al.

Diabetes, obesity & metabolism, 2026

GLP-1
STUDY

A subphenotype of obesity with reduced enteroendocrine GLP-1 synthesis and enhanced tirzepatide response

Ticho AL, McRae AN, Cifuentes L, et al.

Gastroenterology, 2026

GLP-1 tirzepatide
STUDY

Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care

Samajdar SS, Joshi S, Saboo B, et al.

Diabetology international, 2026;17(3):59

GLP-1 Semaglutide tirzepatide
STUDY

Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma

Müller HL

Frontiers in endocrinology, 2026;17:1768254

Property Support

Our Property Support services are designed to help homeowners, property managers, and businesses maintain safe, clean, and well-functioning properties year-round.